Your area Not set — showing everywhere
Issue · Burlington, MA

Kratom Regulation

Board of Health reviewing regulation of kratom sales amid concerns over synthetic forms and school access versus pain-management use.

Overview

The Board of Health began examining kratom regulation after a staff presentation on synthetic variant risks, forming a subcommittee that later reported without taking action. Residents have advocated for continued access based on personal medical benefits while the board gathers more data on regional and state approaches.

Background

Kratom regulation first surfaced at the April 14, 2026 Board of Health meeting when Director Susan Luminello presented data on risks associated with synthetic kratom (7-hydroxymitragynine) and its unregulated sale in local establishments.

This presentation prompted the board to form a subcommittee to investigate potential local regulations and regional collaboration, establishing a formal review process.

The subcommittee's work culminated in a report delivered at the June 23, 2026 meeting, where members reviewed municipal regulations, public comments, state legislation, and approaches in neighboring towns, weighing options such as outright bans against age restrictions like sales limited to those 21 and older.

Two residents, Melody and Laura Romney, testified at the June meeting about kratom's personal benefits for pain management, directly countering the earlier safety-focused presentation and illustrating the tension between individual use and regulatory concerns.

A resident also invited the board to an upcoming kratom education presentation by the City of Sharon, supplying additional external data for consideration.

No regulatory action was taken at either meeting; the board instead deferred decisions pending further research on neighboring municipalities and state trends.

The issue remains unresolved, with the subcommittee continuing discussions without a timeline for final recommendations.

How it unfolded
Director Susan Luminello presented data on risks of synthetic kratom and unregulated sales; board formed a subcommittee to research regulations and potential regional collaboration.
2026-04-14Board Of Health
Subcommittee delivered report reviewing municipal regulations, public comments, state legislation, and neighboring town approaches; citizens Melody and Laura Romney testified on personal pain-management benefits; board received report with no regulatory action taken and directed further research.
2026-06-23Board Of Health
Arguments in favor
Synthetic kratom poses safety risks and is sold unregulated in local establishments.
board-of-health 2026-04-14
For
Potential for widespread access among students requires vigilance even if no major usage has been seen yet.
board-of-health 2026-04-14
For
More research is needed on neighboring municipalities and state regulations before any local action.
board-of-health 2026-06-23
For
Arguments against
Natural kratom provides effective pain management and helps regain mobility for chronic conditions.
board-of-health 2026-06-23
Against
Federal agencies have not moved to ban kratom, supporting continued legal access.
board-of-health 2026-06-23
Against
Regulation rather than a total ban would protect those who rely on natural kratom while addressing synthetic variants.
board-of-health 2026-04-14
Against
Key voices
“Shared personal experience using kratom to manage chronic facial nerve pain and regain mobility; urged board to keep alternative products legal.”
Laura Romneyboard-of-health 2026-06-23
“Natural kratom has been vital for chronic pain; urged regulation rather than a total ban.”
Shannonboard-of-health 2026-04-14
“Presented data on risks of synthetic kratom and its unregulated sale in local establishments.”
Director Susan Luminelloboard-of-health 2026-04-14
What's next

Further research will be conducted on neighboring municipalities and state regulations; the subcommittee will continue discussions.

kratomregulationBoard of Health